Pathology: Page 35

HNC treatment location affects patient morbidity
By DrBicuspid.com staff writers
Patients with head and neck cancer (HNC) receiving radiation treatment at an academic center have a higher survival rate than those receiving treatment at a community center, according to a new study in Otolaryngology -- Head and Neck Surgery.
December 11, 2012
Dose study disputes bitewing-meningioma link
By Kathy Kincade
A study published in Cancer earlier this year prompted outcry in the dental community because it claimed to have found a link between exposure to dental bitewings and increased risk of developing a certain type of brain tumor. But a new study that provides in-depth organ dose data following exposure to bitewing x-rays calls those findings into question.
December 11, 2012
2008 09 05 12 47 03 795 Radiation 70
Caffeinated coffee may reduce oral cancer risk
By DrBicuspid.com staff writers
A new American Cancer Society study finds a strong inverse association between caffeinated coffee intake and oral/pharyngeal cancer mortality.
December 9, 2012
U.K. 'falls short' in awareness of HPV-oral cancer link
By DrBicuspid.com staff writers
The results of a new survey have suggested that Brits are poorly educated when it comes to sexually transmitted diseases such as human papillomavirus (HPV) and its link to oral cancer.
December 9, 2012
Study yields strategy to prevent, halt perio disease
By DrBicuspid.com staff writers
Scientists from the University of Pennsylvania have demonstrated the ability to both prevent periodontitis from developing and halt the progression of the disease once it has developed, according to study in the Journal of Immunology.
December 6, 2012
Study: Oral exams poor predictors of oral cancer
By Donna Domino
Clinical oral exams remain the most common technique for detecting abnormal oral mucosal changes. However, they are poor predictors of dysplasia and oral squamous cell carcinoma (OSCC) diagnoses, according to a meta-analysis in the December Journal of the American Dental Association.
December 6, 2012
2011 12 21 16 36 48 952 Uvula Tongue Tonsils 70
Grant extends oral cancer biomarker research
By DrBicuspid.com staff writers
The National Center for Advancing Translational Sciences has awarded nearly half a million dollars to the Clinical and Translational Science Institute at the University of California, San Francisco for a collaborative research project that includes New York University, Oregon Health and Science University, and Providence Cancer Center.
December 3, 2012
10-year trial yields insight into larynx preservation
By DrBicuspid.com staff writers
Sequential and concurrent chemoradiotherapy produce similar survival rates for locally advanced laryngeal cancer, but the concurrent approach more often allows the larynx to be preserved, according to a 10-year study published in the Journal of Clinical Oncology.
December 2, 2012
Another study links HPV and laryngeal cancer
By DrBicuspid.com staff writers
Chinese researchers have established a link between human papillomavirus (HPV) and laryngeal cancers, and estimate that it increases risk by five times, according to a study in the Journal of Infectious Diseases (November 21, 2012).
November 29, 2012
Study finds link between perio disease, CAD
By Rabia Mughal
A new study in the Journal of Periodontology that looked at the relationship between oral health and coronary artery disease (CAD) in Pakistan found that poor oral health indicators were significantly associated with the disease.
November 29, 2012
2009 11 10 15 53 30 283 Hearthealth 70
NIDCR grant funds oral cancer pain project
By DrBicuspid.com staff writers
The National Institute of Dental and Craniofacial Research (NIDCR) has awarded a joint administrative supplement grant to Brian Schmidt, DDS, of the Bluestone Center for Clinical Research at the New York University (NYU) College of Dentistry, and Markus Hardt, PhD, a protein chemist at the Boston Biomedical Research Institute, to study the molecular mechanisms of oral cancer pain.
November 28, 2012
Molecular saliva test detects oral cancer, diabetes
By Donna Domino
A Pennsylvania start-up is gearing up to launch a molecular saliva test that analyzes biomarkers to detect oral cancer and diabetes. PeriRx is now conducting clinical trials of its diagnostic test, which has attracted the interest of the U.K.'s National Institute for Health Research.
November 27, 2012
2012 11 20 14 52 16 933 Neil Gottehrer 70
Previous Page
Page 35 of 87
Next Page